YOLFTbeta
09

Amicogen Inc

092040 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

1,013.00KRW+13.00 (+1.30%)

Price History

Full chart

Market Stats

Previous Close1,000.00
Open996.00
Day Range995.00 – 1,020.00
52-Week Range787.00 – 3,940.00
Volume239.84K
Market Cap69.82B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.16
50-Day Avg1,003.78
200-Day Avg1,466.43

About

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company develops, produces, and sells of enzymes and new materials; and produces food-related additives and health functional food. It manufactures and sells of biopharmaceutical materials and resins for purifying pharmaceutical proteins and health and beauty products. In addition, the company offers oral incurable and rare disease treatments, as well as manufactures and sells of pharmaceutical raw materials, animal drugs, human drugs, etc. The company was incorporated in 2000 and is headquartered in Jinju-Si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOPiao Zhe
  • Employees236
  • Headquarters14-10, Wolasan-ro, Jinju-Si, South Korea, Korea
  • Websitehttps://www.amicogen.com

Leadership

  • Piao ZheChief Executive Officer

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue27.33B32.46B68.97B73.67B94.52B115.18B115.86B124.88B144.30B159.90B173.60B41.98B
Growth (%)-+18.75%+112.49%+6.81%+28.31%+21.86%+0.59%+7.79%+15.55%+10.82%+8.57%-75.82%
Cost of Revenue12.39B20.53B45.22B48.87B64.00B66.69B70.92B79.93B98.26B104.78B123.12B36.47B
Gross Profit13.70B11.93B23.75B24.80B30.52B48.50B44.93B44.95B46.04B55.13B50.48B5.51B
Gross Margin50.12%36.75%34.43%33.67%32.29%42.10%38.79%35.99%31.91%34.47%29.08%13.13%
Operating Expense4.26B9.59B19.57B26.86B29.09B48.69B44.45B52.69B54.84B56.13B61.41B20.62B
Operating Income9.43B2.34B4.18B-2.06B1.44B-189.93M482.66M-7.75B-8.80B-1.00B-10.92B-15.11B
Operating Margin34.51%7.20%6.06%-2.80%1.52%-0.16%0.42%-6.20%-6.10%-0.63%-6.29%-36.00%
EBITDA---------30.45B1.37B-26.34B-12.49B
EBITDA Margin---------21.10%0.86%-15.17%-29.75%
Net Income7.56B2.07B1.59B-4.61B40.17B86.72M31.60B3.73B-47.22B-23.29B-52.79B-29.96B
Net Income Margin27.67%6.36%2.30%-6.25%42.50%0.08%27.28%2.99%-32.72%-14.56%-30.41%-71.36%
R&D2.05B2.29B2.81B4.77B5.18B-6.28B10.84B12.44B13.78B12.61B7.45B
R&D as % of Total Revenue7.49%7.05%4.08%6.48%5.48%-5.42%8.68%8.62%8.62%7.26%17.74%
Interest Expense0000001.36B2.95B7.46B11.34B10.24B7.75B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%1.17%2.36%5.17%7.09%5.90%18.47%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets54.37B159.84B146.33B163.51B231.21B241.40B283.37B411.22B429.65B467.10B294.23B231.86B
Total Liabilities4.35B77.74B64.79B74.32B103.93B119.35B130.43B225.06B297.86B248.12B171.73B136.00B
Total Equity49.73B82.10B81.54B89.19B127.28B122.05B152.94B186.16B131.80B175.84B122.50B94.57B
Cash8.62B19.63B13.19B13.46B12.21B21.45B30.79B26.32M9.23M24.33B9.36M6.24B
Total Debt-25.53B22.38B23.34B34.26B38.16B42.12B-----
Net Debt------11.49B55.60B122.39B124.10B112.52B86.85B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.43B12.34B11.28B11.88B2.84B8.76B8.87B8.07B-22.41B8.64B-13.34B-24.42B
Investing Cash Flow-511.56M-29.06B-15.82B-31.86B-11.19B-3.74B-2.10B-98.55B-72.45B-58.26B-23.68B-
Financing Cash Flow922.57M27.75B-1.87B20.64B7.31B4.29B2.92B83.98B89.65B54.18B16.58B-
Capital Expenditure4.60B7.32B16.95B11.45B10.88B19.26B13.85B47.31B45.91B62.60B49.82B3.77B
Free Cash Flow------15.73B-7.38B-49.15B-69.73B-53.96B-63.15B-28.20B
Dividends Paid1.07B1.07B911.58M---------
FCF to OCF------179.52%-83.24%-608.72%311.13%-624.35%473.58%115.44%

Earnings

Report DateSep 30, 2013Dec 31, 2013Mar 31, 2014Aug 14, 2014Nov 10, 2014Feb 3, 2015May 15, 2015Aug 17, 2015Nov 13, 2015Feb 3, 2016May 16, 2016Aug 12, 2016Nov 11, 2016Feb 9, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Mar 7, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 13, 2019May 15, 2019Aug 14, 2019Nov 13, 2019Mar 16, 2020May 4, 2020Aug 4, 2020Nov 3, 2020Feb 9, 2021May 17, 2021Aug 17, 2021Nov 9, 2021Mar 14, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Mar 7, 2023May 15, 2023Aug 14, 2023Nov 7, 2023Mar 13, 2024May 16, 2024Aug 12, 2024Nov 5, 2024Mar 11, 2025May 14, 2025Aug 12, 2025Dec 14, 2025Dec 31, 2025May 12, 2026Jun 30, 2026Dec 14, 2026
EPS Estimate---371.00132.50------------------------------------------------
EPS Actual7.9772.7740.8993.50136.00229.5148.3141.87-43.8468.01109.80-22.17-67.3265.52-9.8629.81-55.50-204.35107.00966.009.671062.361287.20-1252.02-605.88560.79-491.001273.00396.00466.65-96.002432.00-1044.00-1037.08-441.00-563.0025.00-1412.0795.84-159.84-12.91-399.30-101.36-170.0816.99-708.79-104.25-109.40-233.60-96.25314.51-294.51-
Surprise----74.80%2.64%------------------------------------------------
Timing---Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-market-Pre-market

Key Statistics & Ratios

Market Cap69.82B
Enterprise Value115.05B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.50
Price / Book0.56
Revenue (TTM)46.69B
Gross Profit (TTM)7.96B
EBITDA-4.89B
Profit Margin-41.33%
Operating Margin-20.69%
Return on Equity-16.77%
Return on Assets-3.88%
Shares Outstanding70.45M
Shares Float64.93M
Beta0.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20151×
22.72Dec 29, 2015
20141×
27.27Dec 29, 2014

Stock Splits

  • Dec 13, 20232:1
  • Oct 23, 2023684:631
  • Apr 2, 20182:1
  • Jun 21, 20172102:2071
  • Aug 22, 20142:1